Search research articles
Contact Us
Filters
Showing results (201-210 of 257) with videos related to
Page
of 26
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 27, 2016
APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian Carcinoma
Brandon Leonard, Gabriel J Starrett, Matthew J Maurer, et al.
Cancer
|
November 13, 2019
Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models
Janice M Santiago-O'Farrill, S John Weroha, Xiaonan Hou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 16, 2020
The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer
Artur A Serebrenik, Prokopios P Argyris, Matthew C Jarvis, et al.
Plos One
|
February 6, 2013
Multi-platform analysis of microRNA expression measurements in RNA from fresh frozen and FFPE tissues
Christopher P Kolbert, Rod M Feddersen, Fariborz Rakhshan, et al.
Journal of the National Cancer Institute
|
May 23, 2018
Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy
Cheyne Kurokawa, Ianko D Iankov, S Keith Anderson, et al.
BMC Medical Genomics
|
December 22, 2010
Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platform
Monica M Reinholz, Jeanette E Eckel-Passow, S Keith Anderson, et al.
Mayo Clinic Proceedings
|
May 26, 2020
Marked Up-Regulation of ACE2 in Hearts of Patients With Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2-Mediated COVID-19
J Martijn Bos, Virginia B Hebl, Ann L Oberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 23, 2026
Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase 2 blinded biomarker validation and panel discovery study
Ann L Oberg, William R Bamlet, Grant Izmirlian, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 21, 2025
Phase II study of the efficacy and safety of palbociclib in patients with recurrent ovarian cancer
Gottfried E Konecny, Tara M Davidson, Coriolan L Lebreton, et al.
Gynecologic Oncology
|
September 12, 2016
In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma
Mariam M AlHilli, Marc A Becker, S John Weroha, et al.
Page
of 26
Search research articles
Search
Showing results (201-210 of 257) with videos related to
Sort By:
Page
of 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 27, 2016
APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian Carcinoma
Brandon Leonard, Gabriel J Starrett, Matthew J Maurer, et al.
Cancer
|
November 13, 2019
Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models
Janice M Santiago-O'Farrill, S John Weroha, Xiaonan Hou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 16, 2020
The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer
Artur A Serebrenik, Prokopios P Argyris, Matthew C Jarvis, et al.
Plos One
|
February 6, 2013
Multi-platform analysis of microRNA expression measurements in RNA from fresh frozen and FFPE tissues
Christopher P Kolbert, Rod M Feddersen, Fariborz Rakhshan, et al.
Journal of the National Cancer Institute
|
May 23, 2018
Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy
Cheyne Kurokawa, Ianko D Iankov, S Keith Anderson, et al.
BMC Medical Genomics
|
December 22, 2010
Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platform
Monica M Reinholz, Jeanette E Eckel-Passow, S Keith Anderson, et al.
Mayo Clinic Proceedings
|
May 26, 2020
Marked Up-Regulation of ACE2 in Hearts of Patients With Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2-Mediated COVID-19
J Martijn Bos, Virginia B Hebl, Ann L Oberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 23, 2026
Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase 2 blinded biomarker validation and panel discovery study
Ann L Oberg, William R Bamlet, Grant Izmirlian, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 21, 2025
Phase II study of the efficacy and safety of palbociclib in patients with recurrent ovarian cancer
Gottfried E Konecny, Tara M Davidson, Coriolan L Lebreton, et al.
Gynecologic Oncology
|
September 12, 2016
In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma
Mariam M AlHilli, Marc A Becker, S John Weroha, et al.
Page
of 26